<DOC>
	<DOC>NCT01975454</DOC>
	<brief_summary>Teng-Long-Bu-Zhong-Tang (TLBZT) is a modern anti-cancer herbal formula. Experimental studies have confirmed the anti-cancer potential of TLBZT against colorectal cancer. This trial will evaluate the safety and efficacy of TLBZT based herbal therapy in combination with chemotherapy in patients with metastatic colorectal cancer.</brief_summary>
	<brief_title>Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer</brief_title>
	<detailed_description>A phase I/II, multicentric,randomized, controlled clinical trial.</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Histologically confirmed adenocarcinoma of the colon or rectum with nonresectable metastatic disease; Ages between 18 and 70 years; Measurable lesion; Karnofsky Performance Status ≥ 60%; Estimated life expectancy of at least 6 months; Participants have no major organ dysfunction and chemotherapy contraindications: hemoglobin ≥90g/L, N &gt; 1.5×10^9/L, PLT≥ 100×10^9/L, normal liver and kidney function; Informed consent from the patient. Symptomatic brain metastasis; Adjuvant or neoadjuvant treatment for nonmetastatic disease in past 6 months; Serious disease of heart, liver, kidney with severe dysfunction; Serious complications, such as gastrointestinal tract obstruction and hemorrhage; Pregnancy or breastfeeding women; Mental or cognitive disorders; Be participating other drug trials; Who are allergic to the study drug.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Metastatic colorectal cancer</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Traditional Chinese Medicine (TCM)</keyword>
	<keyword>Teng-Long-Bu-Zhong-Tang</keyword>
</DOC>